What is BEAM's P/E ratio?

BEAM THERAPEUTICS INC (BEAM) currently trades at a P/E ratio of 12.49.

BEAM THERAPEUTICS INC reports a Return on Equity (ROE) of -5.59%.

What is BEAM's dividend yield?

BEAM THERAPEUTICS INC offers a dividend yield of 0.00%.

What is BEAM's Deepscope Quality Score?

Deepscope rates BEAM's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BEAM?

Deepscope's AI Timing Score for BEAM is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BEAM belong to?

BEAM THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu BEAM (NASDAQ) | BEAM THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

BEAM

BEAM THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 29.40

-3.44 (-10.48%) Day Change

Watchlist Portfolio Compare Chart

12.49

P/E

0.10

D/E

-5.6%

ROE

-4.4%

ROA

0.00%

Div Yield

1.46

PEG

BEAM THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 29.40 Price -3.44 (-10.48%) Day Change	NEWS SCORE: 99

BEAM Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	29.40
PBV / Sector	2.62 / 4.63
Earning Per Share	-0.63

PE / Sector	12.49 / 17.43 GOOD
PEG or PE/Growth / Sector	1.46 / 0.53
Average 1M Daily Value	60.63 M
Average 1W Daily Value	69.24 M

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-39.66 / 449.48
NPM Average (%) / Sector	-239.93 / -1,506.49
NPM Change Average (%) / Sector	344.19 / 4,940.99 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-4.39 / 30.58
ROA Average (%) / Sector	-14.91 / -347.17
ROA Change Average (%) / Sector	28.81 / 5,125.52 GREAT
ROE (%) / Sector	-5.59 / -3.58
ROE Average (%) / Sector	-23.26 / 40.65
ROE Change Average (%) / Sector	28.40 / 2,109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

Chi tiết đăng ký

Analyze Date	2026-06-06 09:08:27
Symbol	BEAM
Name	BEAM THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	102.88 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	3,052.43 / 8,857.28

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 238 Main Street, Cambridge, MA, United States, 02142

Phone: 857 327 8775

Website: https://beamtx.com

Employees: 522

Sector: Healthcare >> Biotechnology

Description: Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparticle (LNP) for the treatment of severe alpha-1 antitrypsin deficiency; BEAM-304, a liver-targeting LNP for the treatment of phenylketonuria; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease type 1a. The company also develops the ESCAPE platform, which combines antibody-based conditioning with multiplex gene edited HSCs. In addition, it develops BEAM-103, an anti-CD117 monoclonal antibody that enables ESCAPE. The company has research collaboration agreement with Pfizer Inc., focusing on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Verve Therapeutics, Inc., for cardiovascular disease treatments; and Orbital Therapeutics to design RNA for the prevention, treatment, or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.